$13.21
-0.190 (-1.42%)
At Close: Jun 22, 2026
Cramer Shares His Thoughts On Slack, Archer Daniels Midland And More
01:17pm, Tuesday, 28'th Apr 2020
On CNBC's "Mad Money Lightning Round," Jim Cramer said that Archer Daniels Midland Co (NYSE: ADM) is a chronic underperformer. Those who like it for yield, should buy Verizon Communications Inc. (NYSE
InMode (NASDAQ:INMD) vs. CONMED (NASDAQ:CNMD) Head-To-Head Review
05:36am, Saturday, 25'th Apr 2020
InMode (NASDAQ:INMD) and CONMED (NASDAQ:CNMD) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitabilit
Reviewing AxoGen (NASDAQ:AXGN) & InMode (NASDAQ:INMD)
05:36am, Saturday, 25'th Apr 2020
AxoGen (NASDAQ:AXGN) and InMode (NASDAQ:INMD) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutiona
12 Short Squeeze Candidates To Watch
06:07pm, Friday, 17'th Apr 2020
One of the most powerful tradable market events is a short squeeze, so traders are always on the lookout for the next short squeeze candidate. S3 Partners analyst Ihor Dusaniwsky has just released a l
Zacks.com featured highlights include: DHT, Blucora, InMode and Enphase Energy
02:12pm, Thursday, 09'th Apr 2020
Zacks.com featured highlights include: DHT, Blucora, InMode and Enphase Energy
4 Stocks With High Net Income Ratio to Scoop Up
03:22pm, Wednesday, 08'th Apr 2020
Profitability analysis is one of the best ways to evaluate the prospects of a company.
4 Stocks With High Net Income Ratio to Scoop Up
01:42pm, Wednesday, 08'th Apr 2020
Profitability analysis is one of the best ways to evaluate the prospects of a company.
InMode to Report First Quarter 2020 Financial Results on May 6, 2020
12:00pm, Tuesday, 07'th Apr 2020
InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its results for the first quarter 2020 before the Nasdaq market ope
The Zacks Analyst Blog Highlights: InMode, Integer, Cardinal Health, DaVita and The Ensign Group
01:46pm, Monday, 06'th Apr 2020
The Zacks Analyst Blog Highlights: InMode, Integer, Cardinal Health, DaVita and The Ensign Group
5 Stocks to Buy for 5 Good Reasons
08:33pm, Friday, 03'rd Apr 2020
Here are 5 ways to make the most of a difficult market.
6 Defensive Stocks Worth Buying As Coronavirus Cases Rise
12:48am, Wednesday, 01'st Apr 2020
Given the current economic slowdown, we have shortlisted six defensive stocks that can return well on investment.
6 Defensive Stocks Worth Buying as Coronavirus Cases Rise
02:06pm, Tuesday, 31'st Mar 2020
The current economic slowdown led by rise in coronavirus cases calls for investing in defensive stocks.
InMode (INMD) Gets a Buy Rating from Barclays
05:44pm, Thursday, 26'th Mar 2020
Barclays analyst
Jack Meehan
maintained a
Buy
rating on InMode (
INMD
–
Research Report
) today and set a price target of
$36.00
. The company’s shares closed last Monday at $23.80.
According to
T
InMode Provides COVID-19 Business Update
12:47pm, Monday, 23'rd Mar 2020
InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today provided an update regarding its business activities in light of the ongoing global health si
InMode Is Back to Its Prior Low: What's Next for This Former High Flyer?
05:13pm, Friday, 20'th Mar 2020
During the Mad Money program host Jim Cramer makes time for callers to ask about securities they are interested in. InMode makes a skin rejuvenation device I could use about now, but let's look at th
Sign In
Buy INMD